Hikma Pharmaceuticals Plc 07 November 2024 Hikma Pharmaceuticals PLC Outcome of Audit Tender Process LONDON, 7 November 2024 - Hikma Pharmaceuticals PLC ('the Company' or 'Hikma...
Hikma Pharmaceuticals PLC on Thursday said it is on track to deliver "another strong performance" following trading t ...
Hikma Pharmaceuticals Plc 07 November 2024 Hikma continues strong strategic execution and reiterates guidance London, 7 November 2024 - Hikma Pharmaceuticals PLC (Hikma, Group), the...
Hikma Pharmaceuticals Plc 24 October 2024 Hikma Pharmaceuticals PLC 2024 Annual General Meeting Update Statement LONDON, 24 October 2024 - Hikma Pharmaceuticals PLC ('Hikma' or 'the...
Hikma Pharmaceuticals Plc 01 October 2024 Hikma Pharmaceuticals PLC Block Listing Six Monthly Return Date: 1 October 2024 Name of applicant: Hikma Pharmaceuticals PLC Name of scheme:...
Hikma Pharmaceuticals Plc 24 September 2024 Hikma Pharmaceuticals PLC (the "Company") LONDON, 24 September 2024: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) (LEI:...
Hikma Pharmaceuticals PLC announced on Tuesday it has completed its acquisition of the US finished dosage form busine ...
Hikma Pharmaceuticals Plc 10 September 2024 Hikma completes Xellia acquisition London, 10 September 2024 - Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -16 | -0.808897876643 | 1978 | 1988 | 1918 | 299027 | 1941.05295449 | DE |
4 | 123 | 6.68841761827 | 1839 | 1993 | 1757 | 622527 | 1855.79668432 | DE |
12 | 38 | 1.97505197505 | 1924 | 2022 | 1757 | 419134 | 1886.77393011 | DE |
26 | 15 | 0.770416024653 | 1947 | 2090 | 1757 | 372632 | 1912.74730358 | DE |
52 | 222 | 12.7586206897 | 1740 | 2165 | 1722 | 426199 | 1900.29964858 | DE |
156 | -246 | -11.1413043478 | 2208 | 2294 | 1174.5 | 567237 | 1785.48131281 | DE |
260 | 64 | 3.37197049526 | 1898 | 2766 | 1174.5 | 596010 | 2024.33533278 | DE |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관